ClinicalTrials.gg
CompletedNCT03479606Updated Oct 6, 2022

Online Emotion Regulation Group Intervention

An interventional study of Online Emotion Regulation Skills-training in Traumatic Brain Injury, Executive Dysfunction and Emotion Dysfunction, sponsored by Icahn School of Medicine at Mount Sinai. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-06.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
137
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will examine the efficacy of an emotion regulation intervention delivered online to individuals with traumatic brain injury (TBI) with deficits in emotion regulation. 104 subjects will be enrolled and will receive 24, 60-minute emotion regulation skills-training sessions twice a week for 12 weeks, delivered online in a group video-conference with 3-5 other participants. Participants will be asked to complete online surveys, lasting approximately 40-50 minutes, every four weeks during the intervention and the 12-week follow-up phase. Attendance and compliance will be tracked, and outcomes will be monitored using online data collection methods.

Read the detailed description

This study will assess the efficacy of an emotion regulation skills-training intervention (Online EmReg) provided online to individuals with TBI with emotion regulation difficulties. Specifically, this study seeks to accomplish three aims: 1) Evaluate the efficacy of the Online EmReg intervention immediately post-intervention and at a 12-week follow-up assessment; 2) Identify factors that optimize the effectiveness of the Online EmReg intervention; 3) Explore the impact of Online EmReg on positive and negative affect, life satisfaction, and executive functioning. The study design is a randomized control trial with a waitlist control group whereby the participants in the control group undergo the training after a 12 week waiting period. 104 subjects with TBI and self-reported deficits in emotion regulation will be enrolled.

The intervention protocol calls for 24, 60-minute emotion regulation sessions twice a week for 12 weeks, delivered online via Zoom by post-doctoral level therapists with specialty training in rehabilitation neuropsychology. Study participation will last approximately 28 weeks for participants in the immediate intervention arm (4 weeks preparation, 12 weeks intervention, 12 weeks follow-up) and 40 weeks for participants in the waitlist arm (4 weeks preparation, 12 weeks waitlist, 12 weeks intervention, and 12 weeks follow-up). Core assessments will be conducted at each major time point: T1 (baseline), T2 (immediate intervention end/waitlist baseline), T3 (immediate intervention follow-up/end of waitlist intervention), and T4 (waitlist follow-up). A subset of the measures will be administered every 4 weeks between each major time point for the duration of the study.

02

Conditions studied

  • Traumatic Brain Injury
  • Executive Dysfunction
  • Emotion Dysfunction
  • Emotion Dysregulation

Keywords

  • Traumatic Brain Injury
  • TBI
  • Executive Dysfunction
  • Emotional Regulation
  • Emotional Dysfunction
  • Problem Solving
  • Self-regulation
  • Cognitive Rehabilitation
  • Metacognitive Strategies
  • Cognitive-behavioral therapy
  • Online Therapy
  • GroupTherapy
  • Group videoconference
  • Telehealth
  • Telerehabilitation
03

In context

Brain Injuries, Traumatic

1,721 studies on the registry are indexed under Brain Injuries, Traumatic; 447 are open to participants now.

This study's enrollment of 137 is above the median of 52 across 1,088 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Icahn School of Medicine at Mount Sinai is the lead sponsor of 776 studies on the registry; 176 are open to participants now.

Of its 125 completed or terminated interventional studies of FDA-regulated products, 83 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • medically documented mild to severe TBI
  • at least 6 months post-injury
  • deficits in emotional regulation (ER), operationalized as a score of 0.5 standard deviations above published means on the Difficulties in Emotion Regulation Scale (DERS; Gratz \& Roemer, 2004)
  • English speaking
  • adequate communication skills, assessed by the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC)
  • access to and ability to use a device that supports GoToMeeting/Zoom, the videoconference software
  • active email address
  • access to the Internet with adequate broadband
  • Lives in the following states for the duration of the 12-week intervention: New York, California, Maryland, North Carolina, Georgia, Missouri, Arizona, New Jersey, Colorado, Florida, or Washington DC

Exclusion criteria

Exclusion Criteria:

  • current alcohol or substance abuse
  • current psychotic disorder, mood disorder with psychotic features or current suicidality, assessed by the Mini International Neuropsychiatric Interview
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
137 participants (actual)

Study arms

  • Experimental
    Immediate Intervention

    Participants will receive 24 online emotional regulation skills-training sessions twice weekly and will complete online questionnaires sent every four weeks throughout baseline, the 12-week intervention, and 12-week follow-up.

    Behavioral: Online Emotion Regulation Skills-training

  • Active comparator
    Waitlist Intervention

    After a 12-week wait-period without any intervention, participants will receive 24 online emotion regulation skills-training sessions. Every four weeks, participants will complete online questionnaires every throughout baseline, 12-week wait-period, 12-week intervention, and 12-week follow-up.

    Behavioral: Online Emotion Regulation Skills-training

Interventions

  • BehavioralOnline Emotion Regulation Skills-training

    Emotion Regulation Training (EmReg) is a cognitive-behavioral approach which aims to increase awareness, and self-monitoring of affective states to improve self-regulation. The intervention is divided into two phases: knowledge provision and practice facilitation. During the knowledge provision phase participants are introduced to the objectives and the main concepts of the intervention, to increase their familiarity with the terminology, and to the emotion regulation skills they acquire during the practice facilitation phase. During the practice facilitation phase participants receive training in emotion regulation skills, which they practice in-session with the guidance of the therapist and feedback from the group, as well as out-of-session as homework assignments.

    Also known as: Emotion Regulation Training (EmReg)

06

What researchers measure

Primary outcomes

  1. Difficulties in Emotion Regulation Scale (DERS)

    36-item self-report questionnaire that focuses on emotional awareness, acceptance, ability to control impulsivity, and flexible use of strategies.

    Time frame: Every 4 weeks for 28 or 40 weeks

Secondary outcomes

  1. Positive Affect Negative Affect Schedule (PANAS)

    A 20-item measure with two independent scales, positive affect and negative affect.

    Time frame: Every 4 weeks for 28 or 40 weeks

  2. Satisfaction with Life Scale (SWLS)

    A 5-item measure of satisfaction with life globally.

    Time frame: Every 4 weeks for 28 or 40 weeks

  3. Problem Solving Inventory (PSI)

    A 35-item self-report measure assessing problem solving behavior and attitudes, the PSI yields 3 subscales: Approach/Avoidance Style, Problem Solving Confidence, and Presence of Personal Control.

    Time frame: Every 4 weeks for 28 or 40 weeks

  4. Dysexecutive Functioning Questionnaire (DEX)

    A 20-item sensitive and ecologically valid questionnaire assessing everyday problems.

    Time frame: Every 4 weeks for 28 or 40 weeks

  5. Transition Ratings (TR)

    These ratings are used to assess change on problems that are intervention targets, from the participant's point of view, by reporting how much better/worse the problem seems to be since the onset of the intervention.

    Time frame: End of intervention (at 16 or 28 weeks) and follow-up at 12-weeks post intervention

  6. Progress Toward Goals (PTG)

    During the first 2 sessions, participants will be asked to set three to five personal goals related to emotional regulation and its impact on their daily lives, and then asked to rate their progress towards these goals on a 7-point Likert scale.

    Time frame: Every 4 weeks for 28 weeks

  7. Skill Acquisition Quiz (SAQ)

    A 20-question content-based quiz developed to assess how well participants learn and retain EmReg concepts and strategies by intervention end.

    Time frame: End of intervention (at 16 or 28 weeks) and follow-up at 12-weeks post intervention

Other outcomes

  1. Access to Care Questionnaire (ACQ)

    A brief questionnaire to assess participants' access to rehabilitation services using modified items borrowed from national health surveys.

    Time frame: Baseline

07

Study locations

1 site
  • The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai
    New York, New York 10029, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03479606
Collaborators
National Institute on Disability, Independent Living, and Rehabilitation Research
Responsible party
Kristen Dams-O'Connor (Professor, Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai) — Principal investigator
First posted
Mar 27, 2018
Start date
Apr 5, 2018
Primary completion
Sep 30, 2022
Completion
Sep 30, 2022
Last update
Oct 6, 2022

Study contacts

Maria Kajankova, PhD
principal investigator · Icahn School of Medicine at Mount Sinai
Kristen Dams-O'Connor, PhD
study director · Icahn School of Medicine at Mount Sinai
Theodore Tsaousides, PhD
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion